New drug CBP-4888 tested in healthy women for first time
NCT ID NCT05881993
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 27 times
Summary
This early-phase study tested a single dose of the investigational drug CBP-4888 in 45 healthy, non-pregnant women to see if it is safe and how the body processes it. Participants received either the drug or a placebo, and researchers monitored for side effects like injection site pain or swelling. This trial does not aim to treat any disease; it simply gathers initial safety information.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER STUDY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Comanche Biopharma Clinical Research Site #1
San Antonio, Texas, 78217, United States
Conditions
Explore the condition pages connected to this study.